A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma

Patients with advanced stomach adenocarcinoma (STAD) commonly show high mortality and poor prognosis. Increasing evidence has suggested that basic metabolic changes may promote the growth and aggressiveness of STAD; therefore, identification of metabolic prognostic signatures in STAD would be meanin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Zaisheng, Zheng, Miao, Zeng, Yi, Wei, Shenghong, Huang, He, Wang, Yi, Liu, Qinying, Lin, Zhitao, Chen, Shu, Zheng, Qiuhong, Chen, Luchuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256842/
https://www.ncbi.nlm.nih.gov/pubmed/34235071
http://dx.doi.org/10.3389/fonc.2021.612952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256842/
https://www.ncbi.nlm.nih.gov/pubmed/34235071
http://dx.doi.org/10.3389/fonc.2021.612952

Ejemplares similares